Cancer Center Membership
Our 500+ members are renowned scientists and clinicians from across Colorado and the Rocky Mountain region who are interested in collaborating with others to understand the basic mechanisms of cancer, discover and create new tests, treatments and therapies, design and participate in clinical trials and pursue solutions for preventing and controlling cancer in our community and across the world.
The University of Colorado Cancer Center has been designated a comprehensive cancer center by the National Cancer Institute of the National Institutes of Health. The CU Cancer Center receives support from the National Cancer Institute under Cancer Center Support Grant (CCSG) P30CA046934 and has 6 members: University of Colorado Denver, University of Colorado Boulder, Colorado State University, University of Colorado Hospital, Children’s Hospital Colorado and the Denver VA Medical Center.
Our ability to maintain this designation and grant is dependent upon having center members that focus on cancer research.
Become a Member
Application for membership is voluntary and connotes agreement by the applicant with the Center's mission, objectives and requirements. Please read the Membership Guidelines prior to applying.
Our Members
This comprehensive resource is designed to facilitate collaboration, highlight expertise, and provide seamless access to key information about University of Colorado Cancer Center members and their groundbreaking work. Whether you're seeking potential collaborators, exploring specialized research areas, or learning more about our community's achievements, this database serves as a vital tool in fostering innovation and progress in the fight against cancer.
Natalie Ahn PhD
Full Member
- Molecular & Cellular Oncology
The Ahn lab explores molecular mechanisms controlling the dynamics of cell signaling in mammalian systems. Our research examines internal motions in protein kinases and their impact on kinase activation and small molecule inhibition, the control of cell polarity and migration by membrane trafficking, and mechanisms for therapy resistance in cancer cells.